Search for: "Ortho-McNeil, Inc."
Results 121 - 140
of 209
Sort by Relevance
|
Sort by Date
10 May 2010, 10:37 am
Ortho-McNeil Pharmaceutical, Inc. v. [read post]
7 May 2010, 11:11 am
See Genentech, Inc. v. [read post]
3 May 2010, 5:08 pm
” Ortho-McNeil Pharm., Inc. v. [read post]
29 Apr 2010, 1:26 pm
Johnson & Johnson and Ortho-McNeil Pharmaceutical, Inc., Civil Action No. 04-11886-WGY. [read post]
29 Apr 2010, 1:26 pm
Johnson & Johnson and Ortho-McNeil Pharmaceutical, Inc., Civil Action No. 04-11886-WGY. [read post]
29 Apr 2010, 2:06 am
The Department of Justice announced on April 29 that Ortho-McNeil Pharmaceutical, LLC, and Ortho-McNeil-Janssen Pharmaceuticals, Inc., two subsidiaries of Johnson & Johnson, have agreed to pay $81 million to settle charges brought in two whistleblower suits that they violated the False Claims Act by promoting Topamax for off-label (unapproved) uses. [read post]
23 Apr 2010, 8:20 am
” Expected to attend are IP leaders from BP America Inc., Merck & Co., Inc., Bose, Brigham Young University, Cornell University, Stanford University, Duke University, Georgetown University, GlaxoSmithKline, Honeywell, Harvard University, Johnson & Johnson, Kauffman Foundation, Lockheed Martin, Massachusetts Institute of Technology (MIT), Mayo Clinic, Ortho-McNeil Pharmaceuticals Inc., Rutgers, Syngenta Biotechnology, Scripps Research… [read post]
7 Apr 2010, 4:30 am
Reddy's Laboratories, Ltd. et al (Docket Report) Retin-A Micro (Tretinoin) – US: District Court E D Texas: Promote Innovation files false marking complaint against Ortho-McNeil based on marking of Retin-A Micro product (Patent Docs) Seasonique (Levonorgestrel, Ethinyl estradiol) – US: Teva receives favourable court decision regarding Seasonique (SmartBrief) (The IP Factor) T2007 (Diphenyl barbituric acid) – US: Taro receives patent for new drug T2007 (The IP… [read post]
31 Mar 2010, 1:58 pm
Prods., Inc. v. [read post]
10 Mar 2010, 5:22 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc. [read post]
10 Mar 2010, 5:22 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc. [read post]
5 Mar 2010, 9:10 pm
Cir. 2007); see also Ortho-McNeil Pharm., Inc. v. [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the patents-in-suit related to method of… [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the patents-in-suit related to method of… [read post]
2 Mar 2010, 5:10 am
Cir. 2007); see also Ortho-McNeil Pharm., Inc. v. [read post]
23 Feb 2010, 9:01 pm
By Suresh Pillai -- Lupin Claims Tri-Cyclen® Patent Invalid Lupin Pharmaceuticals Inc. has filed counterclaims in its suit with Ortho-McNeil-Janssen Pharmaceuticals Inc., alleging that Ortho's patent covering its Tri-Cyclen® Lo contraceptive, U.S. [read post]
17 Feb 2010, 8:00 am
(patent infringement) 1/8: Alza Corporation and Ortho-McNeil-Janssen Pharmaceuticals Inc. v. [read post]
10 Feb 2010, 4:47 pm
(Patent Docs) Opana (Oxymorphone) – US: Endo files patent infringement suit against Roxane in response to Para IV challenge (Patent Docs) Ortho Tri-Cyclen Lo (Ethinyl estradiol, norgestimate) – US:Patent infringement complaint filed in New Jersey following a Paragraph IV certification: Ortho-McNeil-Janssen Pharmaceuticals, Inc. v. [read post]
10 Feb 2010, 11:56 am
See, e.g., Robinson v Ortho-McNeil Pharmaceutical, Inc., 533 F. [read post]
